Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2009
08/06/2009WO2008124081A3 Rapid dissolution of combination products
08/06/2009WO2008100647A9 Therapeutic cooling pad for ophthalmologic and cosmetic use
08/06/2009WO2008051818A8 Spontaneously forming ellipsoidal phospholipid unilamellar vesicles
08/06/2009US20090197849 Transdermal and topical administration of drugs using basic permeation enhancers
08/06/2009US20090197847 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
08/06/2009US20090197846 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
08/06/2009US20090197821 Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment
08/06/2009US20090196937 Temperature-sensitive nano-carriers
08/06/2009US20090196936 Hydrogel wound dressing and biomaterials formed in situ and their uses
08/06/2009US20090196935 Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets
08/06/2009US20090196934 Spherical elementary granule and method for production thereof
08/06/2009US20090196933 Compositions and methods for preparation of poorly water soluble drugs with increased stability
08/06/2009US20090196932 Pharmaceutical compositions of atorvastatin
08/06/2009US20090196931 Therapeutic inhibitor of vascular smooth muscle cells
08/06/2009US20090196930 Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
08/06/2009US20090196929 Silica Wetcake Treatment Method
08/06/2009US20090196928 Biocompatible hydrogel compositions
08/06/2009US20090196927 Polypeptide Inhibitors of HSP27 Kinase and Uses Therefor
08/06/2009US20090196926 Nano-structured thixotropic inorganic peeling gels
08/06/2009US20090196925 Natural product coating for tablets
08/06/2009US20090196924 Controlled-release lamotrigine formulations
08/06/2009US20090196923 Controlled release formulation comprising anti-epileptic drugs
08/06/2009US20090196922 Bilayer tablet for preventing cardiovascular events
08/06/2009US20090196921 Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition
08/06/2009US20090196920 Pharmaceutical composition comprising microcapsules of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa)
08/06/2009US20090196919 Oxcarbazepine dosage forms
08/06/2009US20090196918 Liposomal formulations of hydrophobic lactone drugs in the presence of metal ions
08/06/2009US20090196917 Liposomal Formulations of Hydrophobic Lactone Drugs in the Presence of Metal Ions
08/06/2009US20090196916 Chemoselective ligation of hydrophobic reactants in a lipid phase; thioester and cysteine moieties that are involved in the ligation reaction are positioned within the lipid phase such that the ligation reaction takes place within the lipidic structure
08/06/2009US20090196915 Composition and methods of making and using influenza proteins
08/06/2009US20090196914 Liposomal l-carnitine
08/06/2009US20090196913 Anti-Alpha-V Immunoliposome Composition, Methods, and Uses
08/06/2009US20090196912 Pyridinylamines
08/06/2009US20090196911 Silicone Acrylate Hybride Composition and Method Of Making Same
08/06/2009US20090196910 Sustained-Release Preparation of Statin Drugs
08/06/2009US20090196909 Carbon nanotube containing material for the capture and removal of contaminants from a surface
08/06/2009US20090196908 Edible film-strips with modified release active ingredients
08/06/2009US20090196907 Edible film-strips for immediate release of active ingredients
08/06/2009US20090196904 Highly-mineralized osteogenic sponge compositions and uses thereof
08/06/2009US20090196902 Biogenerator constructed using live cell cultures
08/06/2009US20090196898 Stabilized, sterilized collagen scaffolds with active adjuncts attached
08/06/2009US20090196894 Self Tanning Composition
08/06/2009US20090196890 Pharmaceutical compositions
08/06/2009US20090196889 Controlled absorption of statins in the intestine
08/06/2009US20090196853 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile
08/06/2009US20090196834 Tobacco alkaloid releasing chewing gum
08/06/2009US20090196833 Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome
08/06/2009US20090196832 Novel edible aqueous aerosol foam
08/06/2009US20090196827 Drug Loaded Contrast Agents: Combining Diagnosis and Therapy
08/06/2009US20090196826 Compositions and methods of making non-spherical micro- and nano-particles
08/06/2009US20090194894 Residual solvent extraction method and microparticles produced thereby
08/06/2009US20090194893 Chewable Capsule and Production Method Thereof
08/06/2009DE102008008071A1 Injizierbare biokompatible Zusammensetzung Injectable biocompatible composition
08/06/2009DE102008006791A1 Transdermales Therapeutisches System mit Harnstoff-Komponente Transdermal therapeutic system with urea component
08/06/2009CA2728808A1 Pulmonary formulations of triptans
08/06/2009CA2713946A1 Adhesive patch
08/06/2009CA2713813A1 Intralymphatic chemotherapy drug carriers
08/06/2009CA2713750A1 Preparation of nanoparticles by using a vibrating nozzle device
08/06/2009CA2713679A1 Orally rapidly disintegrating tablet comprising imidafenacin
08/06/2009CA2713677A1 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
08/06/2009CA2713673A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
08/06/2009CA2713459A1 Improved antitumoral treatments
08/06/2009CA2713339A1 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
08/06/2009CA2713266A1 Pharmaceutical composition with gelling properties containing a tyrosine derivative
08/06/2009CA2713242A1 Suspension formulations
08/06/2009CA2713163A1 Galenic form for the oral transmucosal delivery of triptans
08/06/2009CA2712184A1 Method for making patches by electrospray
08/06/2009CA2711774A1 Fentanyl-containing patch for external use
08/06/2009CA2710838A1 Pharmaceutical compositions
08/06/2009CA2710640A1 Transdermal therapeutic system having urea components
08/06/2009CA2705369A1 Biomaterial for the controlled delivery of ingredients
08/06/2009CA2704434A1 Micro- and/or nano-structured packaging material
08/05/2009EP2085402A1 Phosphates of secondary alcohols
08/05/2009EP2085109A2 Transdermal drug delivery devices having coated microprotrusions
08/05/2009EP2085097A1 Highly water-dispersible powder and method of producing the same
08/05/2009EP2085088A1 Adhesive preparation
08/05/2009EP2085087A1 Prodrugs of gaba analogs, compositions and uses thereof
08/05/2009EP2085080A1 Preparation of nanoparticles by using a vibrating nozzle device
08/05/2009EP2085079A2 Process for stabilizing famotidine
08/05/2009EP2085078A1 Controlled porosity osmotic pump tablet of high permeable drugs and the preparation method thereof
08/05/2009EP2085077A1 Coating compositions for controlled relaease formulations
08/05/2009EP2085076A1 Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid
08/05/2009EP2085075A1 Stable shaped particles of crystalline organic compounds
08/05/2009EP2085074A1 Drug microparticles
08/05/2009EP2085073A1 Drug microparticles
08/05/2009EP2085072A1 Drug microparticles
08/05/2009EP2085071A1 Orally or nasally administrable preparations containing epinephrine with improved characteristics
08/05/2009EP2083876A2 Methods of wound care and treatment
08/05/2009EP2083834A2 Macrocyclic lactone compounds and methods for their use
08/05/2009EP2083833A2 Pharmaceutical anti-infective composition for inhalation.
08/05/2009EP2083828A1 A standardised extract and its use in the manufacture of a medicament
08/05/2009EP2083820A1 Pharmaceutical compositions comprising intra- and extra- granular fractions
08/05/2009EP2083803A2 Formulations of active principles incorporated in slns suitable for transdermal administration
08/05/2009EP2083802A2 Treatment with antiarrhythmics and omega-3 fatty acids and a combination product thereof
08/05/2009EP2083801A1 Divisible osmotic dosage forms and methods of use
08/05/2009EP2083800A2 Device and method for patient activated bolus administration
08/05/2009EP2083799A1 Micellar nanoparticles of chemical substances
08/05/2009EP2083798A1 Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate
08/05/2009EP2083797A1 Stable liquid compositions for treating stomatitis comprising epidermal growth factor
08/05/2009EP2083796A2 Enzyme inhibition using nanoparticles
1 ... 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 ... 2991